FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know | Bass, Berry & Sims PLC

The United States Food and Drug Administration (FDA) issued draft guidance on April 13, 2022, entitled, “Diversity Plans to Improve Enrollment of Participants from Underrepresented...

Related Keywords

United States , ,Department Of Health ,European Medicines Agency ,Advisory Committee On Human Research Protections ,Drug Administration ,Human Services Office Of The Inspector ,Berry Sims ,United States Food ,Improve Enrollment ,Underrepresented Racial ,Ethnic Populations ,Ethnicity Diversity Plan ,Diversity Plan ,Investigational New Drug ,Investigational Device Exemption ,Biologics License Application ,New Drug Application ,Diversity Plans ,Human Services Office ,Inspector General ,Advisory Committee ,Human Research Protections ,Common Rule ,From Outside ,